Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
Clinical trial NCT05852847 · UNKNOWN
Trial details
- NCT number
- NCT05852847
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-16
- Primary completion
- 2024-11-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.